Immatics’ PRAME-Directed TCR T-Cell Therapy Drives Deep Remission in Pediatric Solid Tumor Case

Individual experimental treatment attempt at Hopp Children’s Cancer Center Heidelberg (KiTZ) and Heidelberg University Hospital (UKHD) using a TC...

April 21, 2026 | Tuesday | News
Sanofi’s Nuvaxovid Shows Superior Tolerability vs mNEXSPIKE in Head-to-Head Study

Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study First head-to-head, double-blind, randomized phase...

April 21, 2026 | Tuesday | Reports
KIMMTRAK Doubles Five-Year Survival in First-Line Metastatic Uveal Melanoma

KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma OS benefit observed ac...

April 21, 2026 | Tuesday | News
Making Nucleic Acid Therapeutics Manufacturing More Sustainable at Scale

The demand for nucleic acid therapeutics (NATs) is rapidly altering the therapeutic landscape across a wide range of diseases. Recent industry data highlig...

April 20, 2026 | Monday | Expert Opinion
PRAME-Targeted TCR T-Cell Therapy Drives Deep Remission in Pediatric Cancer Case

Individual experimental treatment attempt at Hopp Children’s Cancer Center Heidelberg (KiTZ) and Heidelberg University Hospital (UKHD) using a TC...

April 20, 2026 | Monday | News
MiNK’s agenT-797 Combination Delivers 77% Disease Control Rate in Gastroesophageal Cancer Study

First study of agenT-797, botensilimab (BOT) and balstilimab (BAL) in gastroesophageal cancer shows disease control rate (DCR) in 77% of patients and l...

April 20, 2026 | Monday | News
PacBio and Covaris Unveil Integrated Workflow to Unlock HiFi Sequencing from FFPE Tumor Samples

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, and Covaris, a PerkinElmer company and leader in sample...

April 17, 2026 | Friday | News
Nkarta Advances NKX019 Program with FDA-Aligned Trial Enhancements to Expand Outpatient Access

Expanded treatment in community settings will reduce patient burden Option to redose patients granted in both Ntrust-1 and Ntrust-2 studies Rheumatoi...

April 17, 2026 | Friday | News
BioVersys Initiates Global Phase 3 Trial for BV100 in Drug-Resistant Hospital Pneumonia

BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pne...

April 17, 2026 | Friday | News
Myriad Genetics Secures Japan Approval for MyChoice® as Companion Diagnostic in Prostate Cancer

- Myriad Genetics Inc.,  a leader in molecular diagnostic testing and precision medicine,announced that Japan’s Ministry of Health, Labour and...

April 16, 2026 | Thursday | News
Telix Advances First Radiopharmaceutical Therapy Into Phase III For Glioblastoma Treatment

Telix Pharmaceuticals Limited announces that the first patient has been dosed with TLX101-Tx (¹³¹I-iodofalan) in Telix’s pivota...

April 16, 2026 | Thursday | News
PannTheraPi Advances PTI5803 into Phase 2a for Rare Epilepsy, Secures European Patent and Appoints New CSO

Regulatory submission filed to initiate a Phase 2a trial of its drug candidate, PTI5803 in patients with focal cortical dysplasia (FCD), a rare and sev...

April 15, 2026 | Wednesday | News
Renaissance Pharma Secures FDA Fast Track and IND Clearance for Daretabart in High-Risk Neuroblastoma

FDA grants Fast Track Designation for Daretabart (hu1418K322A), recognising the significant unmet medical need in high-risk neuroblastoma and enabling ...

April 15, 2026 | Wednesday | News
Thermo Fisher Scientific Expands PPD™ Clinical Research Capabilities Through Strategic Data Collaboration with HealthVerity

Thermo Fisher Scientific, the world leader in serving science, announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD...

April 15, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close